Researchers at the University of Chicago have unveiled a new study indicating that taking the prostate cancer drug Zytiga together with a low-fat breakfast boosts the efficiency of the medication. While Zytiga is typically prescribed as a 250mg pill, 4 of which are taken an hour before breakfast, the new study, led by Dr. Russell Szmulewitz, a prostate cancer specialist at the University of Chicago has found that patients "taking one-fourth of the recommended dose with a low-fast breakfast...was just as effective. This, in term has cut drug costs by 75%.
To read more about this study, click here.
No comments:
Post a Comment